Course: Improving Survival Rates and Mitigating Adverse Events with Immunotherapies in Advanced Melanoma
CME Credits: 0.00
Released: 2025-02-10
This enduring activity focusses on the role of immunotherapy for advanced melanoma, its efficacy and safety, as well as strategies to mitigate immunotherapy-associated adverse events. Through case-based learning and expert perspectives, this activity aims to provide clinicians with practical tools and strategies to inform treatment decisions and patient selection for the use of immunotherapy. In addition, this program reviews individualized treatment plans for patients with advanced melanoma.
View Full Course